News | Atherectomy Devices

November 7, 2019 — The REVEAL FDA investigational device exemption (IDE) trial confirmed a favorable safety and ...

Home November 11, 2019
Home
News | Endovascular Aortic Repair

November 7, 2019 — The Endospan Ltd. Nexus aortic arch stent graft is a CE mark–approved, off-the-shelf system for ...

Home November 11, 2019
Home
News | Stents Carotid

November 11, 2019 — Although common femoral artery (CFA) endarterectomy is still considered the gold standard treatment ...

Home November 11, 2019
Home
Earlier this year, Medtronic began a worldwide pivotal study evaluating its investigational Extravascular Implantable Cardioverter Defibrillator (EV ICD) system to treat dangerously fast heart rhythms. The EV ICD system is designed to deliver lifesaving defibrillation and pacing therapy via a device the same size as traditional, transvenous ICDs, but with a lead (thin wire) placed outside the heart and veins. The future of CRM device technology.
Feature | EP Lab | Hrishikesh Kadam

Cardiac rhythm management (CRM) devices in use today are evolving to raise the bar beyond monitoring and managing ...

Home November 11, 2019
Home
News | Cardiovascular Business

November 11, 2019 — ECG Management Consultants, a leading U.S. healthcare advisory firm, is now part of the global ...

Home November 11, 2019
Home
News

November 8, 2019 — Penumbra Inc. announced that the EXTRACT-PE trial successfully met the primary endpoints ...

Home November 08, 2019
Home
News

November 8, 2019 — Dissection is a frequent and clinically problematic outcome of percutaneous transluminal balloon ...

Home November 08, 2019
Home
News

November 8, 2019 — The Absorb bioresorbable stent (BVS) demonstrated good patency and clinical outcomes in patients with ...

Home November 08, 2019
Home
Videos | Nuclear Imaging

American Society of Nuclear Cardiology (ASNC) President Rob Beanlands, M.D., shares a couple trends he sees in cardiac nuclear imaging.

Home November 07, 2019
Home
Videos | Artificial Intelligence

Piotr Slomka explains how his team at Cedars-Sinai is working on intelligent patient risk prediction algorithms...

Home November 07, 2019
Home
News | Vascular Access

November 6, 2019 — Saranas Inc. announced completion of the first U.S. commercial case using its Early Bird Bleed ...

Home November 07, 2019
Home
News | Stents Bioresorbable

November 7, 2019 — Although the Abbott Absorb fully bioresorbable drug-eluting stent (DES) was taken off the market due ...

Home November 07, 2019
Home
News | Drug-Eluting Balloons

November 7, 2019 — Real-world, four-year study results of the In.Pact Admiral drug-coated balloon (DCB) demonstrate long ...

Home November 07, 2019
Home
News | Atherectomy Devices

November 7, 2019 — There was no difference between drug-coated balloons (DCB) vs. plain old balloon angioplasty (POBA) ...

Home November 07, 2019
Home
News

November 6, 2019 — Cleveland Clinic announced the Top 10 Medical Innovations for 2020 at a multimedia presentation last ...

Home November 06, 2019
Home
Subscribe Now